Current methodologies for detecting sensitization to HLA antigens

Area of Science:

• Immunology
• Transplantation Science
• Clinical Chemistry

Background:

• Solid-phase assays represent a significant advancement in detecting and characterizing antibodies against human leukocyte antigen (HLA) antigens.
• These tests have improved access to transplantation for highly sensitized candidates by enabling better assessment of antibody specificities and strengths.
• Understanding antibody profiles is crucial for considering desensitization protocols and managing transplant risks.

Purpose of the Study:

• To review current solid-phase tests for detecting HLA antibodies.
• To evaluate the relevance of these tests in assessing risks for transplant candidates and recipients.
• To discuss the role of these assays in managing sensitized patients.

Main Methods:

• Review of current literature on solid-phase assays for HLA antibody detection.
• Analysis of the clinical relevance and interpretation of solid-phase assay results.
• Discussion of emerging tools for antibody characterization, including isotype and complement fixation.

Main Results:

• Solid-phase assays offer high precision and sensitivity in antibody detection, though clinical relevance can be debated.
• Evidence suggests that low levels of donor-reactive antibodies may not always preclude transplantation.
• Newer assays incorporating isotype and complement fixation analysis show promise in resolving interpretation disparities.

Conclusions:

• Solid-phase tests for HLA antibodies are integral to modern transplantation laboratories worldwide.
• Despite a lack of rigid standardization, these tests are benefiting transplant patients.
• Continued refinement and standardization of solid-phase assays will further optimize their use in clinical transplantation.